Analysis of the trilineage differentiation potential of human pluripotent stem cells (PSCs) using flow cytometry


MBTP 22 = Miltenyi Biotec-tested panel 22

This application protocol describes the quantitative analysis of the trilineage differentiation potential of human pluripotent stem cells (PSCs) using flow cytometry. To demonstrate this state-of-the-art panel for pluripotent stem cell differentiation, PSCs were differentiated using the StemMACS™ Trilineage Differentiation Kit. The StemMACS™ Trilineage Differentiation Kit enables the directed and reproducible differentiation of stem cells into ectodermal, mesodermal, and endodermal lineages ready for downstream applications, such as flow cytometric analysis.

Protocol

Antibody panel

SpecificityClonePurposeFluorochromeDetection filter (nm) (laser)
CD144 (VE-Cadherin)REA199MesodermFITC525/50 (blue)
CD140bREA363MesodermAPC655−730 (red)
CD184 (CXCR4)REA649EndodermAPC655−730 (red)
Sox17REA701EndodermVio® B515525/50 (blue)
PAX-6REA507EctodermAPC655−730 (red)
Sox2REA320EctodermFITC525/50 (blue)
Propidium Iodide Solution-Viability-655−730 (blue)

Gating strategy

Shop required products for this application protocol

7 products found

|